Efficacy and Safety of Risankizumab for the Treatment of Moderate to Severe…
- Resource Type
- Journal
- Language
- Korean
- Region
- Korea
- Price
- $68.00
- Article Title
- Efficacy and Safety of Risankizumab for the Treatment of Moderate to Severe Psoriasis in Korea A Real-Life Experience
- Publication
- Korean Journal of Dermatology
- ISSN
- 0494-4739
- Volume
- 60
- Issue
- 5
- Year
- 2022
- Pages
- 307
- Data Format
- Subject Fields
- Dermatology
- Note
- Full text is usually delivered within 1-2 hours
